(AMP) Amplifon S.p.A - Overview
Sector: Healthcare | Industry: Medical Distribution | Exchange: MI (Italy) | Market Cap: 2.857m EUR | Total Return: -46.7% in 12m
Avg Turnover: 18.2M
EPS Trend: -79.2%
Qual. Beats: 0
Rev. Trend: 95.8%
Qual. Beats: 0
Warnings
Altman Z'' 0.32 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Amplifon S.p.A. is an Italy-based global distributor of hearing solutions and customized fitting services, operating across the EMEA, Americas, and Asia-Pacific regions. The company integrates digital infrastructure into its service model through the Ampli-care platform and the Amplifon App, which allows for real-time device management via smartphone.
As a leader in the Health Care Distributors sub-industry, Amplifon operates within a highly fragmented global retail hearing care market. The business model relies on a combination of proprietary hearing aid brands, such as Ampli-power, and a vast network of physical points of sale to provide specialized audiological care.
Investors can further analyze these market dynamics and valuation metrics on ValueRay. Founded in 1950, the company has scaled its operations to become one of the worlds largest independent hearing aid retailers.
- Strategic acquisitions drive market share gains in fragmented global audiology landscape
- Aging demographic trends fuel long-term organic demand for hearing aid solutions
- High interest rates impact financing costs for aggressive store network expansion
- Private label product mix expansion improves consolidated gross profit margins
- Direct-to-consumer digital platform adoption enhances customer retention and service efficiency
| Net Income: 95.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: -34.35% < 20% (prev -18.47%; Δ -15.88% < -1%) |
| CFO/TA 0.11 > 3% & CFO 414.8m > Net Income 95.6m |
| Net Debt (176.9m) to EBITDA (541.4m): 0.33 < 3 |
| Current Ratio: 0.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (219.9m) vs 12m ago -2.39% < -2% |
| Gross Margin: 54.17% > 18% (prev 56.61%; Δ -2.44% > 0.5%) |
| Asset Turnover: 60.84% > 50% (prev 60.34%; Δ 0.50% > 0%) |
| Interest Coverage Ratio: 3.91 > 6 (EBIT TTM 230.1m / Interest Expense TTM 58.9m) |
| A: -0.21 (Total Current Assets 763.0m - Total Current Liabilities 1.59b) / Total Assets 3.93b |
| B: 0.28 (Retained Earnings 1.10b / Total Assets 3.93b) |
| C: 0.06 (EBIT TTM 230.1m / Avg Total Assets 3.96b) |
| D: 0.38 (Book Value of Equity 1.08b / Total Liabilities 2.85b) |
| Altman-Z'' = 0.32 = B |
| DSRI: 1.02 (Receivables 231.6m/226.8m, Revenue 2.41b/2.41b) |
| GMI: 1.05 (GM 56.61% / 54.17%) |
| AQI: 1.00 (AQ_t 0.63 / AQ_t-1 0.63) |
| SGI: 1.00 (Revenue 2.41b / 2.41b) |
| TATA: -0.08 (NI 95.6m - CFO 414.8m) / TA 3.93b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of June 04, 2026, the stock is trading at EUR 10.59 with a total of 2,138,300 shares traded.
Over the past week, the price has changed by -1.72%,
over one month by +13.98%,
over three months by -12.24% and
over the past year by -46.70%.
Amplifon S.p.A has no consensus analysts rating.
P/E Trailing = 34.7419
P/E Forward = 12.9534
P/S = 1.1964
P/B = 2.171
P/EG = 0.4401
Revenue TTM = 2.41b EUR
EBIT TTM = 230.1m EUR
EBITDA TTM = 541.4m EUR
Long Term Debt = 610.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 692.1m EUR (from shortLongTermDebt, last quarter)
Debt = 486.5m EUR (Leases only: 486.5m)
Net Debt = 176.9m EUR (calculated: Debt 486.5m - CCE 309.6m)
Enterprise Value = 3.03b EUR (2.86b + Debt 486.5m - CCE 309.6m)
Interest Coverage Ratio = 3.91 (Ebit TTM 230.1m / Interest Expense TTM 58.9m)
EV/FCF = 10.24x (Enterprise Value 3.03b / FCF TTM 296.4m)
FCF Yield = 9.77% (FCF TTM 296.4m / Enterprise Value 3.03b)
FCF Margin = 12.30% (FCF TTM 296.4m / Revenue TTM 2.41b)
Net Margin = 3.97% (Net Income TTM 95.6m / Revenue TTM 2.41b)
Gross Margin = 54.17% ((Revenue TTM 2.41b - Cost of Revenue TTM 1.10b) / Revenue TTM)
Gross Margin QoQ = 22.44% (prev none%)
Tobins Q-Ratio = 0.77 (Enterprise Value 3.03b / Total Assets 3.93b)
Interest Expense / Debt = 12.11% (Interest Expense 58.9m / Debt 486.5m)
Taxrate = 35.22% (52.1m / 147.8m)
NOPAT = 149.1m (EBIT 230.1m * (1 - 35.22%))
Current Ratio = 0.48 (Total Current Assets 763.0m / Total Current Liabilities 1.59b)
Debt / Equity = 0.45 (Debt 486.5m / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 0.33 (Net Debt 176.9m / EBITDA 541.4m)
Debt / FCF = 0.60 (Net Debt 176.9m / FCF TTM 296.4m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 95.6m / Total Assets 3.93b)
RoE = 9.04% (Net Income TTM 95.6m / Total Stockholder Equity 1.06b)
RoCE = 13.80% (EBIT 230.1m / Capital Employed (Equity 1.06b + L.T.Debt 610.3m))
RoIC = 6.72% (NOPAT 149.1m / Invested Capital 2.22b)
WACC = 9.60% (E(2.86b)/V(3.34b) * Re(9.90%) + D(486.5m)/V(3.34b) * Rd(12.11%) * (1-Tc(0.35)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -4.60 | Cagr: 0.20%
[DCF] Terminal Value 71.53% ; FCFF base≈293.5m ; Y1≈300.7m ; Y5≈331.6m
[DCF] Fair Price = 15.29 (EV 4.23b - Net Debt 176.9m = Equity 4.05b / Shares 265.2m; r=9.60% [WACC]; 5y FCF grow 2.44% → 2.50% )
EPS Correlation: -79.23 | EPS CAGR: -8.52% | SUE: 0.03 | # QB: 0
Revenue Correlation: 95.84 | Revenue CAGR: 4.88% | SUE: -0.43 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.19 | Chg30d=-13.64% | Revisions=+20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.13 | Chg30d=+44.44% | Revisions=+20% | Analysts=1
EPS current Year (2026-12-31): EPS=0.75 | Chg30d=+1.27% | Revisions=+14% | GrowthEPS=+4.6% | GrowthRev=+1.2%
EPS next Year (2027-12-31): EPS=0.93 | Chg30d=-0.69% | Revisions=+8% | GrowthEPS=+24.5% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +20%